Description
Recombinant monoclonal antibody to CD7. Manufactured using AbAbтАЩs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 3A1E. This is a reformatted human IgG1 Fc SilentтДв antibody, based on the original human IgG2b format, created for improved compatibility with existing reagents, assays and techniques.
Target
CD7
Target Alias Names
Leu9, T-cell antigen CD7, GP40, T-cell leukemia antigen, T-cell surface antigen Leu-9, TP41
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression